Filing Details
Niki BioSolutions, Inc. (NASDAQ:APM) filed a Form 8-K with the Securities and Exchange Commission on July 20, 2026, disclosing a material event.
8k filedNASDAQ:APM
Niki BioSolutions, Inc. (APM) Reports Material Event to SEC
Filing Details Niki BioSolutions, Inc. (NASDAQ:APM) filed a Form 8-K with the Securities and Exchange Commission on July 20, 2026, disclosing a material event. Market Context Niki…
Market Context
Niki BioSolutions, Inc.'s stock currently trades at $0.70 with a market capitalization of $5.0M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Niki BioSolutions, Inc.'s stock.
All SEC filings for Niki BioSolutions, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View APM Stock Page
Frequently Asked Questions
Where can I read APM's SEC filings?
Browse all filings on our APM SEC filings page.
What types of SEC filings does Niki BioSolutions, Inc. file?
Public companies like Niki BioSolutions, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.